Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Beatriz Wills(Memorial Sloan Kettering Cancer Center), Alison J. Moskowitz, Oscar Lahoud(Memorial Sloan Kettering Cancer Center), Paul A. Hamlin, Audrey Hamilton(Memorial Sloan Kettering Cancer Center), Ariela Noy(Memorial Sloan Kettering Cancer Center), Anita J. Kumar(University of Pennsylvania), Heiko Schöder(Memorial Sloan Kettering Cancer Center), Phillip Wong(Memorial Sloan Kettering Cancer Center), W. Thomas Johnson(Office of Education), Gunjan L. Shah(Cornell University), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Brittney Munayirji(Memorial Sloan Kettering Cancer Center), Filiz Şen(United States Fish and Wildlife Service), Helen Hancock(Newcastle University), Santosha A. Vardhana(Memorial Sloan Kettering Cancer Center), Andrew M. Intlekofer(Memorial Sloan Kettering Cancer Center), Connie Lee Batlevi(Memorial Sloan Kettering Cancer Center), Matthew J. Matasar(Rutgers, The State University of New Jersey), Laure Michaud(Memorial Sloan Kettering Cancer Center), Charisse Capadona(Memorial Sloan Kettering Cancer Center), Georgios Pongas(University of Miami), Theresa Davey(Memorial Sloan Kettering Cancer Center), Colette Owens(Memorial Sloan Kettering Cancer Center), Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Joachim Yahalom(Memorial Sloan Kettering Cancer Center), Natasha Galasso(Memorial Sloan Kettering Cancer Center), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Philip Caron(Hôpital Larrey), Ellie Casper(Memorial Sloan Kettering Cancer Center), Alayna Santarosa(Memorial Sloan Kettering Cancer Center), Gilles Salles(Memorial Sloan Kettering Cancer Center), Lorenzo Falchi(Memorial Sloan Kettering Cancer Center), Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Nivetha Ganesan(Memorial Sloan Kettering Cancer Center), Maria Lia Palomba(Memorial Sloan Kettering Cancer Center), Craig H. Moskowitz(University of Miami), Leslie Perez(Memorial Sloan Kettering Cancer Center), David J. Straus(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k